NIH Clinical Center Search the Studies: Study Number, Study Title

Protocol Details

Microbiome and Ocular Inflammatory Disease

This study is NOT currently recruiting participants.

Summary | Eligibility | Citations | Contacts

Summary

Number

13-EI-0072

Sponsoring Institute

National Eye Institute (NEI)

Recruitment Detail

Type: Completed Study; data analyses ongoing
Gender: Male & Female
Min Age: 18 Years
Max Age: 120 Years

Referral Letter Required

Yes

Population Exclusion(s)

Children;
Pregnant Women

Keywords

Oral Tolerance;
Uveitis;
AMD;
Natural History

Recruitment Keyword(s)

None

Condition(s)

Uveitis

Investigational Drug(s)

None

Investigational Device(s)

None

Intervention(s)

None

Supporting Site

National Eye Institute

Background:

- Uveitis is a general term describing a group of inflammatory diseases of the eye. The causes of uveitis are not fully understood. Researchers want to look at bacteria in the body that might be related to the inflammation. They will study the natural bacteria present in the gut and intestines of people with and without uveitis to understand their potential role in these diseases.

Objectives:

- To study the intestinal bacteria in people with and without uveitis or ocular inflammatory disease.

Eligibility:

- Individuals at least 18 years of age who have uveitis or ocular inflammatory disease.

- Individuals at least 18 years of age without uveitis or ocular inflammatory disease to serve as healthy controls.

Design:

- Participants may have more than one study visit (approximately 2-4) to assess possible changes in microbiome composition associated with treatment or disease activity.

- At each visit, participants will have a full eye examination, including vision and eye pressure tests. They will provide blood samples for testing. Participants will also be provided a stool collection kit to take home. The samples may be sent or brought back to the clinic.

- Treatment will not be provided as part of this study.

--Back to Top--

Eligibility

INCLUSION CRITERIA:

Inclusion Criteria for Uveitis Participants

1. Participant must be 18 years of age or older.

2. Participant must have a diagnosis of:

Uveitis (or ocular inflammatory disorder)

3. Participant must be able to undergo slit lamp biomicroscopy.

4. Participant must understand and sign the protocol s informed consent document.

Inclusion Criteria for Healthy Volunteers

1. Participant must be 18 years of age or older.

2. Participant must be able to undergo slit lamp biomicroscopy.

3. Healthy controls will be age-and sex-matched individuals with no personal history of uveitis or other rheumatologic/autoimmune diseases (such as arthritis, inflammatory bowel disease, type 1 diabetes mellitus, psoriasis, Sjorgren s syndrome or multiple sclerosis) and no current use of corticosteroids, disease modifying antirheumatic drugs (DMARDs) including those with antibiotic properties (e.g., gold salts, sulfasalazine, hydroxychloroquine, minocycline) or any immunomodulatory drugs.

4. Participant must understand and sign the protocol s informed consent document.

EXCLUSION CRITERIA:

Exclusion Criteria for Uveitis Participants

1. Participants who are unable to provide informed consent.

2. Recent (<3 months prior) use of any antibiotic therapy

3. Current consumption of probiotics

4. Current extreme diet (parenteral nutrition, macrobiotic diet, etc.)

5. Known gastrointestinal (GI) tract neoplasm

6. Recent GI tract infection (gastroenteritis, colitis, diverticulitis, appendicitis) within the last month

7. Chronic unexplained diarrhea

8. Participant has or had a significant active infection (an infection requiring treatment as determined by the investigator) that required systemic antibiotic treatment within the past three months

9. Participant has any GI tract surgery leaving permanent residua (e.g., gastrectomy; bariatric surgery; colectomy)

10. Participant has inflammatory bowel disease (IBD)

11. Participant is pregnant or lactating.

Exclusion Criteria for Healthy Volunteers

1. Recent (<3 months prior) use of any antibiotic therapy

2. Current consumption of probiotics

3. Current extreme diet (parenteral nutrition, macrobiotic diet, etc.)

4. Known gastrointestinal (GI) tract neoplasm

5. Recent GI tract infection (gastroenteritis, colitis, diverticulitis, appendicitis) within the last month

6. Chronic unexplained diarrhea

7. Participant has or had a significant active infection (an infection requiring treatment as determined by the investigator) that required systemic antibiotic treatment within the past three months

8. Participant has any GI tract surgery leaving permanent residua (e.g., gastrectomy; bariatric surgery; colectomy)

9. Participant has inflammatory bowel disease (IBD)

10. Participant is pregnant or lactating.


--Back to Top--

Citations:

Nussenblatt RB, Gery I, Weiner HL, Ferris FL, Shiloach J, Remaley N, Perry C, Caspi RR, Hafler DA, Foster CS, Whitcup SM. Treatment of uveitis by oral administration of retinal antigens: results of a phase I/II randomized masked trial. Am J Ophthalmol. 1997 May;123(5):583-92.

Presley LL, Ye J, Li X, Leblanc J, Zhang Z, Ruegger PM, Allard J, McGovern D, Ippoliti A, Roth B, Cui X, Jeske DR, Elashoff D, Goodglick L, Braun J, Borneman J. Host-microbe relationships in inflammatory bowel disease detected by bacterial and metaproteomic analysis of the mucosal-luminal interface. Inflamm Bowel Dis. 2012 Mar;18(3):409-17. doi: 10.1002/ibd.21793.

Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Lozupone CA, Turnbaugh PJ, Fierer N, Knight R. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4516-22. doi: 10.1073/pnas.1000080107.

--Back to Top--

Contacts:

Principal Investigator

Referral Contact

For more information:

Emily Y. Chew, M.D.
National Eye Institute (NEI)
NIHBC 10 - CRC BG RM 3-2531
10 CENTER DR
BETHESDA MD 20892
(301) 496-6583
echew@nei.nih.gov

Patti Sherry, C.R.N.O.
National Eye Institute (NEI)
National Institutes of Health
Building 10
Room 10D45
10 Center Drive
Bethesda, Maryland 20892
(301) 435-4529
patti.sherry@nih.gov

Office of Patient Recruitment
National Institutes of Health Clinical Center (CC)
Building 61, 10 Cloister Court
Bethesda, Maryland 20892
Toll Free: 1-800-411-1222
Local Phone: 301-451-4383
TTY: TTY Users Dial 7-1-1
ccopr@nih.gov

Clinical Trials Number:

NCT01859299

--Back to Top--